1. Home
  2. ADPT vs EYE Comparison

ADPT vs EYE Comparison

Compare ADPT & EYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$14.08

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$23.91

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADPT
EYE
Founded
2009
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.1B
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
ADPT
EYE
Price
$14.08
$23.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
9
Target Price
$17.78
$31.22
AVG Volume (30 Days)
1.8M
1.3M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
63.89
202.78
EPS
N/A
0.37
Revenue
$276,976,000.00
$1,987,488,000.00
Revenue This Year
$3.98
$5.56
Revenue Next Year
$22.72
$6.58
P/E Ratio
N/A
$65.27
Revenue Growth
54.77
9.00
52 Week Low
$7.16
$11.90
52 Week High
$20.76
$30.02

Technical Indicators

Market Signals
Indicator
ADPT
EYE
Relative Strength Index (RSI) 49.32 39.59
Support Level $12.22 $22.15
Resistance Level $17.52 $26.07
Average True Range (ATR) 0.84 1.18
MACD 0.06 -0.06
Stochastic Oscillator 54.11 16.75

Price Performance

Historical Comparison
ADPT
EYE

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

Share on Social Networks: